Celldex Therapeutics Stock Profit Margin
| CLDX Stock | USD 27.02 0.80 3.05% |
Celldex Therapeutics fundamentals help investors to digest information that contributes to Celldex Therapeutics' financial success or failures. It also enables traders to predict the movement of Celldex Stock. The fundamental analysis module provides a way to measure Celldex Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celldex Therapeutics stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | (20.55) | (21.57) |
Celldex | Profit Margin |
Celldex Therapeutics Company Profit Margin Analysis
Celldex Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Celldex Therapeutics Profit Margin | -21.57 |
Most of Celldex Therapeutics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celldex Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Celldex Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Celldex Therapeutics is extremely important. It helps to project a fair market value of Celldex Stock properly, considering its historical fundamentals such as Profit Margin. Since Celldex Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Celldex Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Celldex Therapeutics' interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Celldex Pretax Profit Margin
Pretax Profit Margin |
|
Celldex Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Celldex Therapeutics' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Celldex Therapeutics could also be used in its relative valuation, which is a method of valuing Celldex Therapeutics by comparing valuation metrics of similar companies.Celldex Therapeutics is currently under evaluation in profit margin category among its peers.
Celldex Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Celldex Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Celldex Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Celldex Fundamentals
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.2 | ||||
| Operating Margin | (16.34) % | ||||
| Current Valuation | 986.63 M | ||||
| Shares Outstanding | 66.34 M | ||||
| Shares Owned By Institutions | 99.69 % | ||||
| Number Of Shares Shorted | 8.24 M | ||||
| Price To Earning | (2.21) X | ||||
| Price To Book | 2.28 X | ||||
| Price To Sales | 179.69 X | ||||
| Revenue | 6.88 M | ||||
| Gross Profit | (79.9 M) | ||||
| EBITDA | (139.03 M) | ||||
| Net Income | (141.43 M) | ||||
| Cash And Equivalents | 356.82 M | ||||
| Cash Per Share | 7.63 X | ||||
| Total Debt | 2.54 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 12.29 X | ||||
| Book Value Per Share | 11.85 X | ||||
| Cash Flow From Operations | (107.29 M) | ||||
| Short Ratio | 9.03 X | ||||
| Earnings Per Share | (2.58) X | ||||
| Target Price | 67.1 | ||||
| Number Of Employees | 160 | ||||
| Beta | 1.59 | ||||
| Market Capitalization | 1.79 B | ||||
| Total Asset | 465.63 M | ||||
| Retained Earnings | (1.4 B) | ||||
| Working Capital | 400.57 M | ||||
| Current Asset | 294.94 M | ||||
| Current Liabilities | 30.24 M | ||||
| Net Asset | 465.63 M |
About Celldex Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Celldex Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celldex Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celldex Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Celldex Stock Analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.